At eyeforpharma Barcelona 2019, our speakers are pioneering experts in their field of expertise.
Brent Saunders CEO Allergan
Kris Sterkens Company Groups Chairman, Europe, Middle East and Africa Janssen
David Meek CEO Ipsen
Belén Garijo Member of the Executive Board, CEO Healthcare Merck Group
Zach Weinberg Co-Founder Flatiron Health
Gitte Aabo President & CEO LEO Pharma
Mark Mallon Executive Vice President, Global Product and Portfolio Strategy AstraZeneca
Steven Hildemann SVP, Patient Safety and Chief Medical Officer Merck Group
Bharat Tewarie EVP & Chief Marketing Officer UCB
Ryan Olohan Managing Director, Healthcare Google
Marc Princen Executive Vice Presidnet and President, International Business Allergan
Colin Sims Senior Vice President, Head, Transversal Corporate Strategy Sanofi
Kabir Nath President and CEO Otsuka North America
Andrew Thompson Co-Founder and CEO Proteus Digital Health
Andrew Thompson is Co-Founder, President and Chief Executive Officer of Proteus Digital Health. His vision for digital medicine is focused on expanding global access to care, dramatically increasing the value delivered by drugs and creating a more sustainable model for innovation that leverages the mobile device in everyone's pocket.
He is also a Co-Founder and Board Member of Summit Schools, a leading Charter School organization with an acclaimed track record and unique digital platform, featured in the Davis Guggenheim movie “Waiting for Superman”.
Thompson is active in digital humanities innovation as a Member of the Stanford University Libraries and Academic Information Resources Council and with Cambridge University. He is a Co-Founder of Parker Library Online - a leading destination for digital medieval studies.
He holds master’s degrees in Engineering (Cambridge), Education (Stanford) and Business (Stanford GSB) and has a successful 25 year track record starting and building technology-based healthcare companies in Silicon Valley.
Pol Vanderbroucke SVP, Chief Development Officer Pfizer Essential Health
Ana Cespedes Chief Operating Officer IAVI
Florent Edouard SVP, Global Head of Commercial Excellence and Customer Engagement Grünenthal Group
Laurent Abauf Contry President, UK AstraZeneca
Gregory Miller Vice President and Global Head Innovation Accelerator CoE UCB
Gabriel Morelli Global Head of Commercial Excellence Sandoz International
Christina Molt Wengel Senior Vice President and Head of Global Marketing ALK Pharmaceuticals
Dirk Abeel Global Head - Medical Field Effectiveness Nestle
Kasper Jerlang Head of Global Digital Marketing and Engagement LEO Pharma
Irina Osovskaya Global Director of Mobile and Customer Experience Strategy Astrazeneca
Naji Gehchan Chief Marketing Officer & Bio Medicines Leader - France Eli Lilly
Ben Greenberg Vice President, Product Management & User Experience Medscape
Philippe Kirby Director, Customer Engagement Capabilities MSD
David Ventura Head of Marketing Iberia CSL Behring
Inge Bliestle Director, Commercial Operations Actelion
Luis Magarzo Bello Commercial Excellence Head Mylan
Panos Papakonstantinou Musculoskeletal Mobility Solutions Commercial Director Novartis
Jesus Sobrino Spain & Portugal UCB Area Head UCB
Rami Virtanen Global Channel Lead GSK
Davidek Herron Head of Outbound Digital Channels, Europe and Interantional Markets Teva
Peter Hunter-Johnston New Channel Director, eHealth Merck Group
Ed Corbett Principal Novasecta
Casten Grandke Lead Center of Excellence Multichannel Marketing Teva
Lanre Ibitoye Director , Head of Digital Platforms and Capabilites- Europe & International Markets Teva
Roslyn Schneider Global Patient Affairs Lead Pfizer
Cyril Mandry Multichannel Marketing Director- Europe MSD
Gwenan White UK Director of Communications and Patient Relations Abbvie
Simon Bullmore Research Associate Open Data Institute
Simon Bullmore is a research associate at the Open Data Institute (ODI), a non-profit company. Founded by Sirs Tim Berners-Lee and Nigel Shadbolt in 2012, the ODI’s mission is to connect, equip and inspire people around the world to innovate with data. The ODI’s global network includes individuals, businesses, start-ups, franchises, collaborators and governments who help to achieve this mission. Read more about the ODI here.
Marcello Damiani CDO Moderna Therapeutics
Andrew Bate Senior Director, Analytics Team Lead, Epidemiology Pfizer
Cesar Sanz Rodriquez Associate Vice President, Medical Affairs Lead EURAM MSD
Oliver Siegel CEO AFFiRiS
David Montgomery Vice President, Global Science Exchange Pfizer Oncology
Jackie Hunter Chief Executive, Clinical Programmes & Strategic Relationships. Benevolent Bio
Michelle Longmire CEO Medable
Sebastian Sujka CEO & Founder xbird
Dennis Grishna Co-Founder Nebula Genomics
Fabien Astic Chief Business Development Officer Exactcure
Kamal Obbad Co-Founder Nebula Genomics
Frédéric Dayan Chief Executive Officer Exactcure
Lynn Taylor SVP, Global Healthcare Government & Public Affairs Merck Group
Kristin Millburn Head of Partnership Headspace
Martha Caruthers Head of Pharma Partnerships Medopad
Felix Jackson Founder and Medical Director MedDigital
Simon Eade Head Global Commercial Strategy Actelion
Daniel Jackson Global Head, Market Access Solutions and Strategy UCB
Rachel Haurwitz CEO Caribou Bio
Jordi Cabot Managing Director Medtep
Jose Antonio Buron Vidal Vice President EMEA Medical Affairs Johnson & Johnson
Thomas D'Hooghe Vice President and Head, Global Medical Affairs Fertility Merck Group
Mauricio Silva de Lima VP, Medical Europe Roche
Alan Wright Chief Medical Officer Roche Diagnostics
Heather Moses Head of Medical Affairs Roche
Andrew Wright VP Digital Medicines, Vice President, Digital Medicine & Medical Device Division Otsuka Pharmaceutical Companies (U.S.)
David O’Reilly Chief Platform Officer Proteus Digital Health
Giuseppe Rosano Member CVWP, European Medicines Agency, Consultant Cardiologist, Agenzia Italiana del Farmaco EMA
Páll Jónsson Associate Director Science Policy and Research NICE
Rob Thwaites Senior Director, Strategy, Global Outcomes Research (GOR) and Head, GI, GOR Takeda
Christoph von der Goltz Senior Director, Head of HEOR & RWE Lundbeck
Shane Woods Vice President, Life Sciences Flatiron Health
Jennifer Turgiss Vice President, Behavior Science & Advanced Analytics Johnson & Johnson Health and Wellness Solutions
Jennifer Turgiss, DrPH and her team of behavior and data scientists build digital health behavior change interventions targeted toward the individual user (the patient or the consumer) and the health care provider. Dr. Turgiss uses traditional statistical and advanced data science methods to evaluate and optimize the interventions to amplify health and wellbeing.
As an applied scientist and practitioner in population health management, Turgiss spent a decade creating, measuring and optimizing wearable technologies and digital solutions to improve health and wellbeing in the employer market. She holds two patents in this domain. As a business executive, Turgiss worked in several health-related start-ups across the U.S., the U.K., South Africa and Italy. She designed and implemented health and wellbeing programs, including fitness for children, adults, and seniors, sports performance, and weight-, stress-, hypertension- and arthritis-management.
Expertise Snapshot
Sam Behjati Wellcome Trust Intermediate Clinical Fellow Wellcome Sanger Institute
Dirk Vander Mijnsbrugge VP, Medical Affairs Lead International Developed Markets Pfizer
Christopher Keenan Head, Worldwide Medical Customer Engagement, Medical Capabilities BMS
Khair ElZarrad Deptuy Director, Office of Medical Policy FDA
Vladimir Kopernicky Vice President, International Medical Affairs Eli Lilly and Company
Walter Sheloff Customer Facing Medical Effectiveness Lead Pfizer
Martin Price Vice President, Health Economics, Market Access & Reimbursement Janssen
Gillian Leng Deputy Chief Executive Officer NICE
Thomas Temme Head of Value Demonstration & Access & Public Affairs Germany, Austria & Switzerland Shire
Lara Pippo Head of Italy Market Access CSL
Adam Kundzewicz Global Head of Strategic Market Access Initiatives Boehringer Ingelheim
Ulf Staginnus Senior Vice President, Head Global Market Access & Pricing Ipsen
Wim Goettsch Special Advisor HTA, ZINL; Affiliate Associate Professor International Collaboration in HTA, Universiteit Utrecht ZINL
Agathe Le Lay Director, Head of HEOR Lundbeck
Amanda Golembesky Head of Real World Evidence Analytics Center of Excellence Boehringer Ingelheim
Ruediger Papsch Senior Director | Global Head Market Access & Pricing Fertility Merck Group
David Leather Medical Vice President, Respiratory Franchise GSK
Nigel Hughes Scientific Director Janssen
David Van Sickle CEO Propeller Health
Dr Elin Haf Davies CEO Aparito
Daniel Nathrath Founder & Chief Executive Officer Ada Health
Daniel is a serial entrepreneur with 20 years’ experience in strategic growth and transformational change. During his career, he’s founded several startups around the world and served as general counsel and managing director at various tech firms across the UK, US, Denmark and Germany. Daniel was a consultant at the Boston Consulting Group and studied law as a Fulbright Scholar at the University of Houston. He holds an MBA from the University of Chicago.
Joost van der Rijt CEO MS Sherpa
Driven by a personal connect to improve patients’ lives, Joost van der Rijt focuses on creating value in healthcare.
In 2018, he joined Orikami Group (a fast growing healthcare big data company) to accelerate their business and bring the venture MS sherpa to market.
Prior to this, as a strategic marketeer at DSM Biomedical, he expanded the offering through global partnerships.
He has worked for 10 years at Philips Healthcare in marketing and sales roles, to commercialize and build new channels for workflow solutions and value-add services in western and emerging markets.
Medical Affairs Europe
COMMUNITY
eyeforpharma is a registered company in England and Wales - Registered number 09823909. 7-9 Fashion Street, London, E1 6PX, UK.
#efpbarca